Safe Prescribing: Managing Dependence Risks in THC-Based Cannabis Treatments

Join Professor Nicholas Lintzeris in this webinar to learn safe assessment, prescribing, and monitoring of THC treatments for patients at risk of substance use disorders. Covers evidence-based dosing, patient safety, and regulatory compliance.

About the webinar

With the increasing use of medicinal cannabis in Australia, many patients are being prescribed THC-based treatments for conditions such as chronic pain, mental health disorders, and sleep issues.

However, a significant percentage of these patients are at risk of developing cannabis use disorder (CUD) or experiencing cannabis withdrawal symptoms. This one-hour webinar provides healthcare professionals with essential guidance on assessing, prescribing, and monitoring THC-based medicinal cannabis for patients with or at risk of substance use disorders (SUDs).

Participants will learn how to identify at-risk patients, apply evidence-based dosing recommendations, and ensure patient safety through informed consent and regular monitoring. Additionally, we’ll cover regulatory considerations, including the Special Access Scheme-B (SAS-B) and state-level requirements, ensuring compliance with Australian medicinal cannabis guidelines.

Join us to deepen your understanding of how to balance the therapeutic benefits of THC-based treatments with minimising the risks of dependence and misuse.

Learning Outcomes

Recognise key risk factors for cannabis use disorder (CUD) in patients using THC-based medicinal cannabis

Explain the risks of cannabis dependence and withdrawal to patients and obtain informed consent

Apply appropriate dosing strategies and formulation choices for patients with varying cannabis tolerance

Develop a plan for monitoring THC treatment effectiveness and managing potential misuse

About the speaker

Professor Nicholas Lintzeris, a Conjoint Professor in Addiction Medicine at the University of Sydney and Director of Drug and Alcohol Services at South East Sydney Local Health District in NSW, brings a wealth of knowledge and experience in the field of cannabis use and its disorders. He has spearheaded numerous NHMRC funded clinical trials of medicinal cannabis in the treatment of cannabis use disorder and is the lead researcher of the Cannabis As Medicine Surveys, examining consumer experiences of medical cannabis in Australia. In his private practice in Sydney, he prescribes medicinal cannabis, integrating his extensive research and clinical experience.

Webinar

When: Tuesday, 15 April 2025

Time: 7:00 pm

Cost: Free

By registering for this webinar, you consent to receiving communications from Medihuanna and our sponsors related to this event.

Our Sponsors

Claim 1 CPD Hour

Medihuanna is a CPD approved education provider, and this activity has been approved by the RACGP. Upon completing this activity, you will be eligible to claim CPD hours. The activity will include the following CPD allocation which will be uploaded to the RACGP dashboard.